English
Kopran Q4 Results
- BSE: 524280
- NSE: KOPRAN
- ISIN: INE082A01010
- Sector: Biotechnology & Drugs
BSE
142.40
-1.05 (-0.73%)
-1.05 (-0.73%)Volume15.69 K
Updated: Fri 14 Nov, 2025 | 15:46:50
NSE
142.87-0.34 (-0.24%)
-0.34 (-0.24%)Volume2.23 L
Updated: Fri 14 Nov, 2025 | 15:46:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Kopran Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 158.35 | 150.40 | 5.28% | 167.98 | -5.74% |
| Depreciation/ Amortization | 3.87 | 4.00 | -3.20% | 3.59 | 7.65% |
| Operating Income | 14.02 | 15.84 | -11.53% | 18.10 | -22.55% |
| Net Income | 9.68 | 10.40 | -6.91% | 18.62 | -48.03% |
| Other Operating Expenses Total | 21.85 | 25.30 | -13.62% | 23.66 | -7.64% |
| Net Income Before Taxes | 13.71 | 13.86 | -1.06% | 25.18 | -45.54% |
| Total Revenue | 172.36 | 166.24 | 3.68% | 186.08 | -7.37% |
| Selling/ General/ Admin Expenses Total | 17.26 | 15.40 | 12.11% | 12.92 | 33.58% |
| Diluted Normalized EPS | 2.00 | 2.15 | -6.84% | 3.86 | -48.08% |